Citius Pharmaceuticals (CTXR) PT Raised to $8 at Dawson James, Following Strategic Business Update
Tweet Send to a Friend
Dawson James analyst Jason Kolbert ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
